top of page

Growth Strategy

Establishing a healthcare business can be overwhelming and it is easy to forget about the longer term growth opportunities for your products or assets
 
Regardless of whether you have ambitions to build the next life sciences leader, exit an investment after the initial launch or sell the business to a big corporate player, it is critical to understand the full long term growth potential of your business
​
We help you understand and assess all opportunities to maximise the value of your business and assets. Whether it is expanding product labels, adding new features, expanding to global markets or licensing new technologies to your portfolio, we make sure you know how to maximise the value of your assets and portfolio
​
Growth Strategy Services:
​
  • Market expansion assessments and modelling
  • Indication expansion planning
  • Cost - benefit analysis
  • Monetisation strategy
  • Lifecycle strategy and value development
  • Business development and licensing
  • Partnering modelling and negotiation tools
  • Scenario definition and analysis
​
Case Studies
Late-Stage Biopharma
Market Expansion Strategy
A late-stage, listed biotech commissioned us to conduct an international market opportunity  assessment and develop a geographic expansion strategy for their launch asset
​
We led a cross-functional client team as well as external intelligence suppliers to develop a comprehensive recommendation based on NPV and strategic analyses
Late-Stage Biopharma
Lifecycle Strategy & Indication Expansion
We were commissioned by a late-stage, PE-funded start-up to assess potential lifecycle opportunities and develop a recommendation, utilising primary market research, market valuations and strategic opportunity assessments
​
bottom of page